Company Overview

Update
Founded:
2003
Headquarters:
Gaithersburg, MD
IPO:
Went Public on Jan 10, 2014
Stock:
GLYC
Categories:
Health Care, Biotechnology
Description:
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

Detailed Description

Update

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.

Current Team (9)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Headquarters

    101 Orchard Ridge Drive

    Suite 1E

    Gaithersburg, MD 20878

    USA

Images (1)

Update
  • 7a10d2f541d0b3d1dc8770b5082c0d7d